412 related articles for article (PubMed ID: 32817560)
1. Agonist-induced formation of unproductive receptor-G
Okashah N; Wright SC; Kawakami K; Mathiasen S; Zhou J; Lu S; Javitch JA; Inoue A; Bouvier M; Lambert NA
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21723-21730. PubMed ID: 32817560
[TBL] [Abstract][Full Text] [Related]
2. GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling.
Thomsen ARB; Plouffe B; Cahill TJ; Shukla AK; Tarrasch JT; Dosey AM; Kahsai AW; Strachan RT; Pani B; Mahoney JP; Huang L; Breton B; Heydenreich FM; Sunahara RK; Skiniotis G; Bouvier M; Lefkowitz RJ
Cell; 2016 Aug; 166(4):907-919. PubMed ID: 27499021
[TBL] [Abstract][Full Text] [Related]
3. A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling.
Beautrait A; Paradis JS; Zimmerman B; Giubilaro J; Nikolajev L; Armando S; Kobayashi H; Yamani L; Namkung Y; Heydenreich FM; Khoury E; Audet M; Roux PP; Veprintsev DB; Laporte SA; Bouvier M
Nat Commun; 2017 Apr; 8():15054. PubMed ID: 28416805
[TBL] [Abstract][Full Text] [Related]
4. Methods to Monitor the Trafficking of β-Arrestin/G Protein-Coupled Receptor Complexes Using Enhanced Bystander BRET.
Cao Y; Namkung Y; Laporte SA
Methods Mol Biol; 2019; 1957():59-68. PubMed ID: 30919346
[TBL] [Abstract][Full Text] [Related]
5. Lack of beta-arrestin signaling in the absence of active G proteins.
Grundmann M; Merten N; Malfacini D; Inoue A; Preis P; Simon K; Rüttiger N; Ziegler N; Benkel T; Schmitt NK; Ishida S; Müller I; Reher R; Kawakami K; Inoue A; Rick U; Kühl T; Imhof D; Aoki J; König GM; Hoffmann C; Gomeza J; Wess J; Kostenis E
Nat Commun; 2018 Jan; 9(1):341. PubMed ID: 29362459
[TBL] [Abstract][Full Text] [Related]
6. β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor.
Daly C; Guseinov AA; Hahn H; Wright A; Tikhonova IG; Thomsen ARB; Plouffe B
Elife; 2023 Oct; 12():. PubMed ID: 37855711
[TBL] [Abstract][Full Text] [Related]
7. An inactive receptor-G protein complex maintains the dynamic range of agonist-induced signaling.
Jang W; Adams CE; Liu H; Zhang C; Levy FO; Andressen KW; Lambert NA
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30755-30762. PubMed ID: 33199589
[TBL] [Abstract][Full Text] [Related]
8. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
[TBL] [Abstract][Full Text] [Related]
9. Live cell optical assay for precise characterization of receptors coupling to Gα12.
Masuho I; Skamangas NK; Martemyanov KA
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6(Suppl 6):88-95. PubMed ID: 30916867
[TBL] [Abstract][Full Text] [Related]
10. Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation.
Kumari P; Srivastava A; Ghosh E; Ranjan R; Dogra S; Yadav PN; Shukla AK
Mol Biol Cell; 2017 Apr; 28(8):1003-1010. PubMed ID: 28228552
[TBL] [Abstract][Full Text] [Related]
11. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.
Quoyer J; Janz JM; Luo J; Ren Y; Armando S; Lukashova V; Benovic JL; Carlson KE; Hunt SW; Bouvier M
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):E5088-97. PubMed ID: 24309376
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
13. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.
Charest PG; Oligny-Longpré G; Bonin H; Azzi M; Bouvier M
Cell Signal; 2007 Jan; 19(1):32-41. PubMed ID: 16857342
[TBL] [Abstract][Full Text] [Related]
14. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
15. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
[TBL] [Abstract][Full Text] [Related]
16. Detection of β-Arrestin-Mediated G Protein-Coupled Receptor Ubiquitination Using BRET.
Nagi K; Shenoy SK
Methods Mol Biol; 2019; 1957():93-104. PubMed ID: 30919349
[TBL] [Abstract][Full Text] [Related]
17. Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin.
Feinstein TN; Yui N; Webber MJ; Wehbi VL; Stevenson HP; King JD; Hallows KR; Brown D; Bouley R; Vilardaga JP
J Biol Chem; 2013 Sep; 288(39):27849-60. PubMed ID: 23935101
[TBL] [Abstract][Full Text] [Related]
18. Michaelis-Menten Quantification of Ligand Signaling Bias Applied to the Promiscuous Vasopressin V2 Receptor.
Heydenreich FM; Plouffe B; Rizk A; Milić D; Zhou J; Breton B; Le Gouill C; Inoue A; Bouvier M; Veprintsev DB
Mol Pharmacol; 2022 Sep; 102(3):139-149. PubMed ID: 35779859
[TBL] [Abstract][Full Text] [Related]
19. Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.
Namkung Y; LeGouill C; Kumar S; Cao Y; Teixeira LB; Lukasheva V; Giubilaro J; Simões SC; Longpré JM; Devost D; Hébert TE; Piñeyro G; Leduc R; Costa-Neto CM; Bouvier M; Laporte SA
Sci Signal; 2018 Dec; 11(559):. PubMed ID: 30514808
[TBL] [Abstract][Full Text] [Related]
20. Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1.
Ayoub MA; Trinquet E; Pfleger KD; Pin JP
FASEB J; 2010 Sep; 24(9):3522-35. PubMed ID: 20410441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
